Filters
Filters

 

Resource Type
Topic
Show (45)
Cancel
Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
January 18, 2021
Read More
Metrion Biosciences strengthens global business development team
September 8, 2020
Read More
Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines
April 7, 2020
Read More
Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research
December 3, 2019
Read More
Metrion Biosciences appoints Dr Andrew Southan as Chief Executive Officer
April 8, 2019
Read More
Metrion Biosciences Closes Funding Round
April 1, 2019
Read More
Metrion Biosciences and LifeArc sign collaboration agreement for neuroscience-focused ion channel drug discovery
January 29, 2019
Read More
Metrion Biosciences makes senior appointments to strengthen its drug discovery leadership team
September 17, 2018
Read More
Metrion Biosciences and AMRI collaborate to offer ion channel drug discovery services
September 5, 2018
Read More
Metrion Biosciences awarded £637k funding under Innovate UK Biomedical Catalyst Primer Award for ion channel drug discovery
August 28, 2018
Read More
1 2 3 4 5
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram